ADHERENCE PACKAGING MARKET ANALYSIS

Rising packaging costs and regulatory requirements are posing significant challenges for the growth of the global adherence packaging market. Packaging manufacturers are facing increased costs of raw materials like plastic, paper and aluminum used for producing adherence blisters and strip packaging. The prices of oil and plastic resins from which polymers are derived have risen sharply in the past year due to disruption of global supply chains during the pandemic and now due to the ongoing geo-political issues. This has directly translated to higher production costs for adherence packaging.  Additionally, stringent regulatory norms especially in the pharma industry have increased the compliance burden for adherence packaging. Regulators are mandating child resistant packaging and senior friendly designs to prevent accidental misuse. They also requires enhanced tamper evidence features and product theft prevention mechanisms. Compliance to these regulations involved expensive testing and certification process. The packaging designs have become more complex with multilayered materials and advanced sealing technologies to meet the regulations. This has significantly raised the overall R&D and capital investment costs for adherence packaging manufacturers.

Opportunity: Untapped markets in developing countries

Untapped markets in developing countries offer huge potential opportunities for the global adherence packaging market. Regions like Africa, South Asia and parts of Latin America are still in their developmental phases with rising income levels and growing health awareness. As living standards improve gradually in these markets, people are able to afford advanced healthcare and medical solutions which were not priorities or accessible before.  Adherence packaging plays a crucial role in medication management, treatment continuity and overall healthcare outcomes. It helps patients stick to their dosage schedules, take the right medicines on time and complete the course of therapy. This is particularly important for chronic conditions like diabetes, hypertension, asthma etc. which require lifelong treatment adherence. As non-communicable diseases rise worldwide due to lifestyle changes, the needs for adherence solutions will surge substantially. According to World Health Organization, adherence to long-term therapy for chronic illnesses in developing countries averages only 50%. Poor monitoring of drug intake significantly impacts treatment effectiveness and increases risks of complications or re-admissions.